[
  {
    "ts": "2026-02-01T19:06:06+00:00",
    "headline": "Regeneron Pipeline Progress And Valuation Gap Put Future Growth In Focus",
    "summary": "Regeneron Pharmaceuticals (NasdaqGS:REGN) is highlighting progress across its product pipeline, with management pointing to expectations for at least four upcoming FDA approvals. The company is advancing three new molecular entities and expanding late stage clinical trials, alongside recent regulatory wins for EYLEA HD and Dupixent. These developments come alongside strong recent earnings, with management describing this period as an inflection point for the business. Regeneron...",
    "url": "https://finance.yahoo.com/news/regeneron-pipeline-progress-valuation-gap-190606637.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "55f264fc-6153-3a84-92cd-fc8d3e80e7f7",
      "content": {
        "id": "55f264fc-6153-3a84-92cd-fc8d3e80e7f7",
        "contentType": "STORY",
        "title": "Regeneron Pipeline Progress And Valuation Gap Put Future Growth In Focus",
        "description": "",
        "summary": "Regeneron Pharmaceuticals (NasdaqGS:REGN) is highlighting progress across its product pipeline, with management pointing to expectations for at least four upcoming FDA approvals. The company is advancing three new molecular entities and expanding late stage clinical trials, alongside recent regulatory wins for EYLEA HD and Dupixent. These developments come alongside strong recent earnings, with management describing this period as an inflection point for the business. Regeneron...",
        "pubDate": "2026-02-01T19:06:06Z",
        "displayTime": "2026-02-01T19:06:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w30LARiR1Z35GusfaFi.2g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3eDp_RSETU8kXm3usDK_gQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/a52f4d4b48157c0b8b51190845e3ba14.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pipeline-progress-valuation-gap-190606637.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/regeneron-pipeline-progress-valuation-gap-190606637.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]